Ovid Therapeutics, Inc. (OVID)
2.80
-0.13
(-4.44%)
USD |
NASDAQ |
Aug 28, 16:00
2.85
+0.05
(+1.79%)
After-Hours: 07:43
Ovid Therapeutics Shareholders Equity (Quarterly) : 209.89M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 209.89M |
| March 31, 2026 | 198.27M |
| December 31, 2025 | 130.66M |
| September 30, 2025 | 44.70M |
| June 30, 2025 | 55.79M |
| March 31, 2025 | 59.28M |
| December 31, 2024 | 68.23M |
| September 30, 2024 | 76.29M |
| June 30, 2024 | 88.90M |
| March 31, 2024 | 78.28M |
| December 31, 2023 | 87.80M |
| September 30, 2023 | 101.29M |
| June 30, 2023 | 110.70M |
| March 31, 2023 | 120.95M |
| December 31, 2022 | 132.27M |
| September 30, 2022 | 142.05M |
| June 30, 2022 | 152.15M |
| March 31, 2022 | 165.00M |
| December 31, 2021 | 179.75M |
| Date | Value |
|---|---|
| September 30, 2021 | 197.02M |
| June 30, 2021 | 206.71M |
| March 31, 2021 | 221.11M |
| December 31, 2020 | 43.63M |
| September 30, 2020 | 63.64M |
| June 30, 2020 | 30.48M |
| March 31, 2020 | 51.44M |
| December 31, 2019 | 70.02M |
| September 30, 2019 | 30.05M |
| June 30, 2019 | 45.44M |
| March 31, 2019 | 57.25M |
| December 31, 2018 | 38.81M |
| September 30, 2018 | 49.97M |
| June 30, 2018 | 61.12M |
| March 31, 2018 | 72.09M |
| December 31, 2017 | 83.44M |
| September 30, 2017 | 92.96M |
| June 30, 2017 | 100.94M |
| March 31, 2017 | 42.34M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.307B |
| Alnylam Pharmaceuticals, Inc. | 1.354B |
| Anika Therapeutics, Inc. | 137.28M |
| Savara, Inc. | 143.66M |
| Vericel Corp. | 370.04M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 231.97M |
| Total Liabilities (Quarterly) | 22.08M |
| Debt to Equity Ratio | 0.0606 |
| Current Ratio | 12.39 |
| Net Debt Paydown Yield | 0.07% |